+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sickle Cell Anemia Testing & Screening Market - Global Forecast 2026-2032- Product Image
Sickle Cell Anemia Testing & Screening Market - Global Forecast 2026-2032- Product Image
New

Sickle Cell Anemia Testing & Screening Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 195 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5305523
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The sickle cell anemia testing and screening market is undergoing dynamic transformation, driven by advances in diagnostics, shifting healthcare policies, and evolving clinical workflows. For senior decision-makers, clear and actionable intelligence is essential for aligning organizational strategy and operational planning within this complex sector.

Market Snapshot: Sickle Cell Anemia Testing & Screening Market Overview

In the coming years, the sickle cell anemia testing and screening market is set for strong expansion, with market size projected to grow from USD 1.21 billion in 2025 to USD 1.39 billion in 2026 and reaching USD 3.03 billion by 2032. This growth, marked by a notable CAGR of 13.92%, highlights the sector's robust response to clinical need and technological advancement. Underpinned by greater awareness, policy initiatives, and increasing adoption of high-precision diagnostics, market momentum is expected to reshape operational landscapes for providers, payers, and suppliers.

Scope & Segmentation of the Sickle Cell Anemia Testing & Screening Market

This report delivers a comprehensive analysis across core dimensions, equipping stakeholders for data-driven decision-making in a rapidly evolving field.

  • Test Types: The scope includes High Performance Liquid Chromatography (HPLC), enzyme-linked immunosorbent assays and lateral flow immunoassays, as well as molecular assays such as next generation sequencing and polymerase chain reaction, reflecting the market's emphasis on detecting hemoglobinopathies with accuracy and speed.
  • Product Categories: Coverage spans consumables like testing kits and reagents, a variety of instruments including analyzers and chromatography systems, comprehensive molecular diagnostic platforms, and crucial service offerings—maintenance, user training, and specialist consultancy.
  • End Users: The analysis addresses procurement patterns and adoption trends in hospital-based diagnostic laboratories, independent labs, hospitals and outpatient clinics, research institutions, and public health agencies, each vital to widespread implementation and surveillance.
  • Sample Modalities: Capillary and venous blood remain primary specimens, with saliva collection kits gaining traction for remote and outreach screening, facilitating expanded access to underserved populations.
  • Distribution Pathways: The market operates via direct sales (company field teams) and indirect routes such as distributors and online retail platforms, both shaping speed of adoption and post-sale support models.
  • Regional Coverage: The Americas benefit from established screening infrastructure; Europe, Middle East, and Africa blend advanced technologies with scalable low-cost models; Asia-Pacific is characterized by rapid diagnostic innovation amid diverse laboratory capabilities. These regional factors impact strategy, investment, and access.

Key Takeaways for Senior Decision-Makers

  • New assay technologies and innovative sample collection tools are making earlier and more accurate detection widely accessible, supporting improved patient trajectories and long-term health outcomes.
  • Decentralization and optimized logistics now enable screening outreach beyond centralized urban labs, extending reach into high-risk or remote areas.
  • Regulatory environments are advancing toward tighter protocol standardization, increasing sector accountability and elevating product performance criteria for diagnostic providers.
  • The growing integration of laboratory information systems and data analytics is streamlining result interpretation, strengthening public health initiatives, and paving the way for enhanced personalized care models.
  • Procurement and supply chain leaders must anticipate changes linked to global trade and tariffs, prioritizing supplier resilience, cost clarity, and bundled agreements that optimize visibility and cost control.

Tariff Impact Across Diagnostic Supply Chains

Recent shifts in tariff policies have altered the cost structures for internationally sourced instruments, reagents, and supporting components. In response, manufacturers are revisiting procurement frameworks, emphasizing the development of local production capabilities and renegotiating supplier contracts to increase flexibility and mitigate risk. Laboratories must balance meeting rising performance standards with managing operational expenditures, often favoring bundled procurement solutions that streamline both costs and supply continuity.

Research Methodology & Data Sources

This analysis integrates a transparent mixed-methods approach—combining structured literature reviews, targeted interviews with subject matter experts, and validation through regulatory and technical documentation. The process ensures findings remain rooted in current clinical and operational realities, instilling confidence for leadership planning.

Why This Report Matters

  • Supports executive teams in aligning technology investment with evolving clinical, policy, and operational priorities for both near-term decisions and long-range strategy.
  • Clarifies the dynamic interplay among market trends, policy frameworks, and innovation drivers—essential for robust risk management, procurement, and regional growth initiatives.
  • Provides guidance for tailoring go-to-market strategies by geography, fortifying supply chain resilience, and promoting equitable patient access across healthcare systems.

Conclusion

By leveraging these insights, senior leaders can steer their organizations through the rapid evolution in sickle cell anemia diagnostics. Integrating innovative technologies and resilient supply practices encourages sustainable adoption and measurably improves population health outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Sickle Cell Anemia Testing & Screening Market, by Product
8.1. Consumables
8.1.1. Kits
8.1.2. Reagents
8.2. Instruments
8.2.1. HPLC Systems
8.2.2. Immunoassay Analyzers
8.2.3. Molecular Diagnostic Platforms
8.3. Services
8.3.1. Maintenance & Support
8.3.2. Training & Consultancy
9. Sickle Cell Anemia Testing & Screening Market, by Test Type
9.1. High Performance Liquid Chromatography
9.2. Immunoassay
9.2.1. Enzyme Linked Immunosorbent Assay
9.2.2. Lateral Flow
9.3. Molecular Assay
9.3.1. Next Generation Sequencing
9.3.2. Polymerase Chain Reaction
10. Sickle Cell Anemia Testing & Screening Market, by Sample Type
10.1. Blood Sample
10.1.1. Capillary Blood
10.1.2. Venous Blood
10.2. Saliva Sample
10.2.1. Collection Kits
10.2.2. Direct Collection
11. Sickle Cell Anemia Testing & Screening Market, by End User
11.1. Diagnostic Laboratories
11.1.1. Hospital Based Labs
11.1.2. Independent Labs
11.2. Hospitals & Clinics
11.2.1. Private Clinics
11.2.2. Public Hospitals
11.3. Research Institutes
11.3.1. Academic Institutions
11.3.2. Government Research Centers
12. Sickle Cell Anemia Testing & Screening Market, by Distribution Channel
12.1. Direct
12.2. Indirect
12.2.1. Distributors
12.2.2. Online Retail
13. Sickle Cell Anemia Testing & Screening Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Sickle Cell Anemia Testing & Screening Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Sickle Cell Anemia Testing & Screening Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Sickle Cell Anemia Testing & Screening Market
17. China Sickle Cell Anemia Testing & Screening Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Alpha Laboratories
18.7. Analytical Services International
18.8. Atlas Medical
18.9. Beam Therapeutics, Inc.
18.10. Becton, Dickinson and Company
18.11. Bio-Rad Laboratories, Inc.
18.12. BioMedomics, Inc.
18.13. bluebird bio, Inc.
18.14. CRISPR Therapeutics AG
18.15. Daktari Diagnostics, Inc.
18.16. DiaSorin S.p.A.
18.17. F. Hoffmann-La Roche Ltd
18.18. Halcyon Biomedical, Inc.
18.19. HEMEX HEALTH
18.20. HemoTypeSC
18.21. Laboratory Corporation of America Holdings
18.22. Ortho Clinical Diagnostics, Inc.
18.23. PerkinElmer, Inc.
18.24. QIAGEN N.V.
18.25. Request A Test, Ltd.
18.26. Siemens Healthineers AG
18.27. Silver Lake Research Corporation
18.28. STRECK, Inc.
18.29. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HPLC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HPLC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HPLC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTIC PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTIC PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTIC PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TRAINING & CONSULTANCY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TRAINING & CONSULTANCY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TRAINING & CONSULTANCY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY LATERAL FLOW, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY LATERAL FLOW, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY LATERAL FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MOLECULAR ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MOLECULAR ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MOLECULAR ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY BLOOD SAMPLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY BLOOD SAMPLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY BLOOD SAMPLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY BLOOD SAMPLE, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CAPILLARY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CAPILLARY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CAPILLARY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY VENOUS BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY VENOUS BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY VENOUS BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SALIVA SAMPLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SALIVA SAMPLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SALIVA SAMPLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SALIVA SAMPLE, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY COLLECTION KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY COLLECTION KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY COLLECTION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIRECT COLLECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIRECT COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIRECT COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HOSPITAL BASED LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HOSPITAL BASED LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HOSPITAL BASED LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INDEPENDENT LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INDEPENDENT LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PRIVATE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PRIVATE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIRECT, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIRECT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INDIRECT, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INDIRECT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INDIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY BLOOD SAMPLE, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SALIVA SAMPLE, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY BLOOD SAMPLE, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SALIVA SAMPLE, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY BLOOD SAMPLE, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SALIVA SAMPLE, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY BLOOD SAMPLE, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SALIVA SAMPLE, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
TABLE 195. EUROPE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. EUROPE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 197. EUROPE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 198. EUROPE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 199. EUROPE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 200. EUROPE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 201. EUROPE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 202. EUROPE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 203. EUROPE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 204. EUROPE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY BLOOD SAMPLE, 2018-2032 (USD MILLION)
TABLE 205. EUROPE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SALIVA SAMPLE, 2018-2032 (USD MILLION)
TABLE 206. EUROPE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. EUROPE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 208. EUROPE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 209. EUROPE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 210. EUROPE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 211. EUROPE SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 220. MIDDLE EAST SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY BLOOD SAMPLE, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SALIVA SAMPLE, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 225. MIDDLE EAST SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 226. MIDDLE EAST SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 227. MIDDLE EAST SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 228. MIDDLE EAST SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
TABLE 229. AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 230. AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 231. AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 232. AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 233. AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 234. AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 235. AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 236. AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 237. AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 238. AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY BLOOD SAMPLE, 2018-2032 (USD MILLION)
TABLE 239. AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SALIVA SAMPLE, 2018-2032 (USD MILLION)
TABLE 240. AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 242. AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 243. AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 244. AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 245. AFRICA SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
TABLE 246. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 248. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 249. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 250. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 251. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 252. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 253. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 254. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 255. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY BLOOD SAMPLE, 2018-2032 (USD MILLION)
TABLE 256. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SALIVA SAMPLE, 2018-2032 (USD MILLION)
TABLE 257. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 258. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 259. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 260. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 261. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 262. ASIA-PACIFIC SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
TABLE 263. GLOBAL SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 264. ASEAN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 265. ASEAN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 266. ASEAN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 267. ASEAN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 268. ASEAN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 269. ASEAN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 270. ASEAN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 271. ASEAN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 272. ASEAN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 273. ASEAN SICKLE CELL ANEMIA TESTING & SCREENING MARKET SIZE, BY BLOOD SAMPLE, 2018-2032 (USD MILLION)
TABL

Companies Mentioned

The key companies profiled in this Sickle Cell Anemia Testing & Screening market report include:
  • Abbott Laboratories
  • Alpha Laboratories
  • Analytical Services International
  • Atlas Medical
  • Beam Therapeutics, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioMedomics, Inc.
  • bluebird bio, Inc.
  • CRISPR Therapeutics AG
  • Daktari Diagnostics, Inc.
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • Halcyon Biomedical, Inc.
  • HEMEX HEALTH
  • HemoTypeSC
  • Laboratory Corporation of America Holdings
  • Ortho Clinical Diagnostics, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Request A Test, Ltd.
  • Siemens Healthineers AG
  • Silver Lake Research Corporation
  • STRECK, Inc.
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.39 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.03 Billion
Compound Annual Growth Rate13.9%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Rapid Point-of-Care Testing for Sickle Cell Anemia Market Size, Share & Trends Analysis Report by Type (Lateral Flow Immunoassay, Paper-based Rapid Diagnostics), Technology, Age Group, Distribution Channel, End-use, and Region with Growth Forecasts, 2025-2030 - Product Image

Rapid Point-of-Care Testing for Sickle Cell Anemia Market Size, Share & Trends Analysis Report by Type (Lateral Flow Immunoassay, Paper-based Rapid Diagnostics), Technology, Age Group, Distribution Channel, End-use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 320 Pages
  • Global
From
Sickle Cell Anemia Testing and Screening Market - Global Strategic Business Report - Product Image

Sickle Cell Anemia Testing and Screening Market - Global Strategic Business Report

  • Report
  • 371 Pages
  • Global
From
Anemia Treatment Market Report by Disease Type, Therapy Class, Route of Administration, Countries and Company Analysis, 2025-2033 - Product Image

Anemia Treatment Market Report by Disease Type, Therapy Class, Route of Administration, Countries and Company Analysis, 2025-2033

  • Report
  • 200 Pages
  • Global
From
Renal Anemia Market Report and Forecast 2025-2034 - Product Image

Renal Anemia Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Anemia Diagnostic Solution Market - Global Forecast 2026-2032 - Product Image

Anemia Diagnostic Solution Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.